UPDATE: The Post has comments from the doctor. He never examined A-Rod. He merely reviewed A-Rod’s MRI at his request. His verdict: he didn’t say anything significant on the MRI. That said, he takes great pains to say that he wasn’t giving a formal second opinion and is in no position to say whether or not A-Rod can play. It was merely his take on the MRI.
Which sorta makes it sound like A-Rod is doctor shopping with the purpose of getting some sort of message across in what one can only assume is a pretty tense showdown between he and the Yankees regarding his ability to play. Or about the P.R. component regarding whether he is able to play. Which isn’t quite the same thing.
1:30 PM: This is simply delicious:
Is he faking? Are the Yankees keeping him out on purpose? Is the doctor crazypants? Are these things mutually-exclusive? I’d say (a) maybe; (b) maybe; (c) maybe; (d) no.
And that no matter what the truth is here, someone is gonna come out looking bad. Either A-Rod for appearing to be hiding, the Yankees for being unwilling — possibly out of P.R. concerns — to activate a player who might actually improve their team, even if it’s just for a week or two before Bud’s hammer comes down.
As for the doctor: man, this guy sure does speak out of turn a lot for a dude who is supposed to keep client confidentiality. Probably worth noting that doctors can only do that if their patient tells them they can …
As for the Yankees: boy, A-Rod being totally healthy sure would look bad for their alleged attempts to get insurance to cover his contract on some disability retirement scheme. It’s almost as if someone in A-Rod’s position would like to see the Yankees squirm a bit here. It’s almost as if they’d like him to STFU. Hmm …
All I know is that I hope it’s A-Rod who is seen as the bad actor here. He’s murdered 19 people after all, so I’m sure he can take the heat.
Ben Nicholson-Smith of Sportsnet.ca reports that the Blue Jays and right-hander Jesse Chavez had an arbitration hearing on Friday, with a decision expected today.
Chavez, who was acquired from the Athletics this offseason, requested $4 million and was offered $3.6 million by the Blue Jays when arbitration figures were exchanged last month. Toronto is known as a “file-and-trial” team, so they bring these cases to a hearing unless a multi-year deal can be reached. The three-person panel of arbitrators will choose one salary or the other.
Chavez, 32, posted a 4.18 ERA and 136/48 K/BB ratio in 157 innings across 26 starts and four relief appearances last season. He’s expected to compete for the fifth spot in Toronto’s rotation this spring.
After trading Ender Inciarte to the Braves as part of the Shelby Miller deal, Yasmany Tomas will go into 2016 as a regular in the Diamondbacks’ lineup. Signed to a six-year, $68.5 million contract in December of 2014, Tomas batted .273 with nine home runs and a .707 OPS over 426 plate appearances during his first season in the majors last year while struggling defensively between third base and right field. Third base is out as a possibility at this point, but the Diamondbacks are mulling over another defensive change for him.
According to Nick Piecoro of the Arizona Republic, Diamondbacks manager Chip Hale said Friday that the club has discussed moving Tomas to left field and David Peralta to right.
“We’re definitely talking about it,” Hale said. “(Outfield coach) Dave McKay and I, (General Manager Dave Stewart) and (Chief Baseball Officer) Tony (La Russa), we think it might be best to switch them around.”
When the third base experiment flopped, the Diamondbacks put Tomas in right because they felt he would be the most comfortable there. The metrics weren’t kind to him. He’ll now have a full spring training to work on things if the club decides to make a change. Peralta isn’t the defender that Inciarte was, but he’s better than Tomas, so it’s understandable why the Diamondbacks would change their alignment.
Tomas is likely to be a liability no matter where he plays, but the Diamondbacks won’t mind as much if his bat begins to meet expectations. For a team with designs on the postseason, he’s a big key for this lineup.
The Associated Press is reporting that the Cubs and starter Jake Arrieta have avoided arbitration, agreeing to a $10.7 million salary for the 2016 season. That marks the highest salary on a one-year deal for a pitcher with four years of service, the AP notes. Arrieta and the Cubs were set to go before an independent arbitrator but now can simply focus on the season ahead.
Arrieta, 29, is in his second of three years of arbitration eligibility. He had filed for $13 million while the Cubs countered at $7.5 million. The $5.5 million gap was the largest among players who did not come to terms with their respective teams by the January deadline. The $10.7 million salary is $450,000 above the midpoint between the two submitted figures.
Arrieta won the National League Cy Young Award for his performance this past season, narrowly edging out Zack Greinke, then with the Dodgers. Arrieta led the majors with 22 wins, four complete games, and three shutouts. With that, he compiled a 1.77 ERA and a 236/48 K/BB ratio across 229 innings.
Once a top prospect in the Orioles’ minor league system, Arrieta struggled in the majors but found immediate success with the Cubs in 2013 after the O’s traded him along with Pedro Strop in exchange for Steve Clevenger and Scott Feldman.
Per Baseball America’s Matt Eddy, the Giants have signed infielder Conor Gillaspie to a minor league deal. Gillaspie was selected by the Giants in the supplemental round of the 2008 draft, then was traded to the White Sox in February 2013.
Gillaspie, 28, hit a meager .228/.269/.359 with four home runs and 24 RBI in 253 plate appearances between the White Sox and Angels during the 2015 season. Almost all of his playing time has come at third base but he can also play first base if needed.
The Giants, thin on depth, will allow Gillaspie to audition in spring training for a spot on the 25-man roster.